Malignant gastric granular cell tumor

Summary

Malignant gastric granular cell tumor (MONDO:0001057) is a cancer. A subtype of gastric cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	malignant gastric granular cell tumor
Mondo ID	MONDO:0001057
DOID	DOID:10536
NCIT	C5484
UMLS	C1334585
MedGen	233664
GARD	0022870
Is cancer (heuristic)	yes

Also known as: malignant gastric granular cell neoplasm · malignant gastric granular cell tumor · malignant granular cell neoplasm of stomach · malignant granular cell neoplasm of the stomach · malignant granular cell stomach neoplasm · malignant granular cell stomach tumor · malignant granular cell stomach tumour · malignant granular cell tumor of stomach · malignant granular cell tumor of the stomach · malignant granular cell tumour of the stomach

Disease family

This is a subtype of gastric cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system cancer › gastric cancer › malignant gastric granular cell tumor

Related subtypes (8): gastric lymphoma, pylorus cancer, cardia cancer, malignant gastric germ cell tumor, gastric leiomyosarcoma, gastric liposarcoma, gastric carcinoma, diffuse gastric cancer

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.